It is essential for pharmaceutical companies to evaluate many factors when choosing a clinical supply chain partner.

With today’s global focus on vaccine development, the need for excellence in clinical cold chain distribution and storage has never been more acute. This white paper addresses the key questions to help guide the conversation as you evaluate prospective supply chain partners.

You can rely on as your clinical supply chain partner because we are a wholly owned subsidiary of UPS and the essential clinical part of UPS Healthcare. With Marken, BOMI Group, and Polar Speed included, the UPS Healthcare network staffs 199 locations with 10,000+ employees worldwide.

To read our complete white paper, Evaluating a Clinical Supply Chain Partner to Meet Your Vaccine Trial Needs, request a copy below.